Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Protego Biopharma
AddedFeb 17, 2024
UpdatedJun 18, 2026
Protego Biopharma

Protego Biopharma

Protego Biopharma, founded in 2011, develops safe, effective therapeutics, including Tafamidis, from genetic links.

HQ
San Diego, CA, US
Founded
2011
Overview
Compare
Fundraising
Employees
Website

Protego Biopharma, founded in 2011 and headquartered in San Diego, California, is dedicated to developing therapeutics that leverage clear human genetic links. The company's core mission is to create safe and effective treatments for protein misfolding diseases. Their product lineup includes Tafamidis, a disease-modifying agent. Protego Biopharma focuses on drug discovery and development, utilizing genetic evidence and bioinformatics to target specific protein misfolding disorders.

Notable figures affiliated with Protego Biopharma include leading scientists and biotech entrepreneurs, although specific names are not provided. The company has achieved significant milestones in demonstrating the efficacy and safety of its therapeutics, particularly with Tafamidis. Protego Biopharma's impact lies in its innovative approach to addressing protein misfolding diseases, potentially offering new hope for patients with these challenging conditions.

Protego Biopharma - Similar Companies

Chaperone Therapeutics logo

Chaperone Therapeutics

Proteotech logo

Proteotech

ProFound Therapeutics logo

ProFound Therapeutics

profoundtx.com

ProThera Biologics logo

ProThera Biologics

Origami Therapeutics, Inc. logo

Origami Therapeutics, Inc.

Gain Therapeutics logo

Gain Therapeutics

EpiBiologics logo

EpiBiologics

epibiologics.com

Rectify Pharmaceuticals logo

Rectify Pharmaceuticals

rectifypharma.com

Differentiated Therapeutics logo

Differentiated Therapeutics

dxtherapeutics.com

Neomorph logo

Neomorph

neomorph.com

Biotheryx logo

Biotheryx

biotheryx.com

TeraFold Biologics logo

TeraFold Biologics

Prosetta logo

Prosetta

prosetta.com

Entact Bio logo

Entact Bio

entactbio.com

76Bio logo

76Bio

76bio.com

Protego Biopharma - Quick Facts

Who are Protego Biopharma's competitors?

Companies similar to Protego Biopharma include Chaperone Therapeutics, Proteotech, ProFound Therapeutics and ProThera Biologics.

When was Protego Biopharma founded?

Protego Biopharma was founded in 2011.

Where is Protego Biopharma's headquarters located?

Protego Biopharma's headquarters is located in San Diego, CA, US.

When was Protego Biopharma's last funding round?

Protego Biopharma's most recent funding round was for $51M (USD) in October 2021.

How much has Protego Biopharma raised to-date?

As of Oct 19, 2021, Protego Biopharma has raised a total of $51M (USD).

How many employees does Protego Biopharma have?

Protego Biopharma has 20 employees as of Feb 5, 2024.

Protego Biopharma - Classification

Ownership
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Tafamidis
  • Therapeutics
Tags
  • Data Information
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 13 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified